What happened (operation and performance updates for PMBJP)
The Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) reported operation and performance details for the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), which works through Jan Aushadhi Kendras. The implementing agency identified in the government reply is the Pharmaceuticals & Medical Devices Bureau of India (PMBI). The reported information covers scheme objectives, scale of Kendras, sales and visit indicators, and awareness activities used to improve acceptance and sales.
Objectives of PMBJP (what the scheme is meant to achieve)
The government lists the following objectives of PMBJP:
Make available quality medicines, medical devices, and consumables at affordable prices for all and reduce out-of-pocket expenditure for consumers/patients.Popularise generic medicines among the masses and dispel the notion that low-priced generics are of inferior quality or are less effective.Ensure easy availability of menstrual health services to all women across India.Generate employment by engaging individual entrepreneurs in opening Jan Aushadhi Kendras.
Reported scale, sales, and visitation of Jan Aushadhi Kendras
Related current affairs
- PMBJP: 20,149 Jan Aushadhi Kendras operational; medicines up to 50–80% cheaper and quality ensured
- Jan Aushadhi Kendras (JAKs) performance and expansion under PMBJP scheme
- PMBJP: 20,149 Jan Aushadhi Kendras and sales details (Rajya Sabha reply)
- Schemes to strengthen pharmaceutical and bulk drug manufacturing in Maharashtra
- Parliamentary panel flags under-utilisation of allocations in Department of Pharmaceuticals schemes and highlights corrective measures
- Indian pharma sees little immediate threat from Trump’s 200% tariff plan